New drug ATTO1310 tested for itch relief – first human trial underway
Symptom relief
Ongoing
This early-stage study tests ATTO1310, an experimental drug, for safety in healthy adults, people with eczema (atopic dermatitis), and those with long-term itching. About 108 participants will receive either the drug or a placebo and be monitored for side effects. The goal is to …
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC